PeopleSoft for the Oracle DBA

por Kurtz, David
Publicado 2012

PeopleSoft for the Oracle DBA

por Kurtz, David
Publicado 2005

Bringing circulating tumor DNA to the clinic in Hodgkin lymphoma

por Kurtz, David M.
Publicado 2021

The neural computation of inconsistent choice behavior

por Kurtz-David, Vered, Persitz, Dotan, Webb, Ryan, Levy, Dino J.
Publicado 2019

The emergence of the tetrathionate reductase operon in the Escherichia coli/Shigella pan‐genome

por Adsit, Floyd G., Randall, Thomas A., Locklear, Jacqueline, Kurtz, David M.
Publicado 2022

Organocatalytic Removal of Formaldehyde Adducts from RNA and DNA Bases

por Karmakar, Saswata, Harcourt, Emily M., Hewings, David S., Lovejoy, Alexander F., Kurtz, David M., Ehrenschwender, Thomas, Barandun, Luzi J., Roost, Caroline, Alizadeh, Ash A., Kool, Eric T.
Publicado 2015

A mathematical model of ctDNA shedding predicts tumor detection size

por Avanzini, Stefano, Kurtz, David M., Chabon, Jacob J., Moding, Everett J., Hori, Sharon Seiko, Gambhir, Sanjiv Sam, Alizadeh, Ash A., Diehn, Maximilian, Reiter, Johannes G.
Publicado 2020

Time Since Last Anti-CD20 Treatment Is a Major Determinant of Sars-Cov-2 Vaccine Response in a Large Cohort of Patients with B-Cell Lymphoma

por Shree, Tanaya, Shankar, Vishnu, Czerwinski, Debra K., Rodriguez, Gladys, Beygi, Sara, Schroers-Martin, Joseph G, Advani, Ranjana, Maeda, Lauren S., Gupta, Neel K., Khodadoust, Michael S., Kurtz, David M., Corbelli, Karen S., Gabriel, Etelka, Kanegai, Alyssa M., Alizadeh, Ash A., Levy, Ronald
Publicado 2021

Polatuzumab vedotin with infusional chemotherapy for untreated aggressive B-cell non-Hodgkin lymphomas

por Lynch, Ryan C., Poh, Christina, Ujjani, Chaitra S., Warren, Edus H., Smith, Stephen D., Shadman, Mazyar, Morris, Karolyn, Lee, Sydney, Rasmussen, Heather, Ottemiller, Susan, Shelby, Megan, Keo, Sarith, Verni, Kaitlin, Kurtz, David M., Alizadeh, Ash A., Chabon, Jacob J., Hogan, Gregory J., Schulz, Andre, Gooley, Ted, Voutsinas, Jenna M., Gopal, Ajay K.
Publicado 2022

Integrated digital error suppression for improved detection of circulating tumor DNA

por Newman, Aaron M., Lovejoy, Alexander F., Klass, Daniel M., Kurtz, David M., Chabon, Jacob J., Scherer, Florian, Stehr, Henning, Liu, Chih Long, Bratman, Scott V., Say, Carmen, Zhou, Li, Carter, Justin N., West, Robert B., Sledge, George W., Shrager, Joseph B., Loo, Billy W., Neal, Joel W., Wakelee, Heather A., Diehn, Maximilian, Alizadeh, Ash A.
Publicado 2016

A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL

por Cherng, Hua-Jay J., Alig, Stefan K., Oki, Yasuhiro, Nastoupil, Loretta J., Fayad, Luis, Neelapu, Sattva S., Turturro, Francesco, Hagemeister, Fredrick, Craig, Alexander F. M., Macaulay, Charles W., Rodriguez, Maria Alma, Lee, Hun Ju, McDonnell, Timothy J., Flowers, Christopher R., Vega, Francisco, Green, Michael R., Feng, Lei, Kurtz, David M., Alizadeh, Ash A., Davis, R. Eric, Westin, Jason R.
Publicado 2022

Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients

por Chabon, Jacob J., Simmons, Andrew D., Lovejoy, Alexander F., Esfahani, Mohammad S., Newman, Aaron M., Haringsma, Henry J., Kurtz, David M., Stehr, Henning, Scherer, Florian, Karlovich, Chris A., Harding, Thomas C., Durkin, Kathleen A., Otterson, Gregory A., Purcell, W. Thomas, Camidge, D. Ross, Goldman, Jonathan W., Sequist, Lecia V., Piotrowska, Zofia, Wakelee, Heather A., Neal, Joel W., Alizadeh, Ash A., Diehn, Maximilian
Publicado 2016

Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients

por Chabon, Jacob J., Simmons, Andrew D., Lovejoy, Alexander F., Esfahani, Mohammad S., Newman, Aaron M., Haringsma, Henry J., Kurtz, David M., Stehr, Henning, Scherer, Florian, Karlovich, Chris A., Harding, Thomas C., Durkin, Kathleen A., Otterson, Gregory A., Thomas Purcell, W., Ross Camidge, D., Goldman, Jonathan W., Sequist, Lecia V., Piotrowska, Zofia, Wakelee, Heather A., Neal, Joel W., Alizadeh, Ash A., Diehn, Maximilian
Publicado 2016

A Comprehensive Circulating Tumor DNA Assay for Detection of Translocation and Copy-Number Changes in Pediatric Sarcomas

por Shah, Avanthi Tayi, Azad, Tej D., Breese, Marcus R., Chabon, Jacob J., Hamilton, Emily G., Straessler, Krystal, Kurtz, David M., Leung, Stanley G., Spillinger, Aviv, Liu, Heng-Yi, Behroozfard, Inge H., Wittber, Frederick M., Hazard, Florette K., Cho, Soo-Jin, Daldrup-Link, Heike E., Vo, Kieuhoa T., Rangaswami, Arun, Pribnow, Allison, Spunt, Sheri L., Lacayo, Norman J., Diehn, Maximilian, Alizadeh, Ash A., Sweet-Cordero, E. Alejandro
Publicado 2021

Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA

por Kurtz, David M., Soo, Joanne, Keh, Lyron Co Ting, Alig, Stefan, Chabon, Jacob J., Sworder, Brian J., Schultz, Andre, Jin, Michael C., Scherer, Florian, Garofalo, Andrea, Macaulay, Charles W., Hamilton, Emily G., Chen, Binbin, Olsen, Mari, Schroers-Martin, Joseph G., Craig, Alexander F.M., Moding, Everett J., Esfahani, Mohammad S., Liu, Chih Long, Dührsen, Ulrich, Hüttmann, Andreas, Casasnovas, René-Olivier, Westin, Jason R., Roschewski, Mark, Wilson, Wyndham H., Gaidano, Gianluca, Rossi, Davide, Diehn, Maximilian, Alizadeh, Ash A.
Publicado 2021